多次复发浅表性膀胱癌患者膀胱内注射丝裂霉素C的研究。
Study of intravesical mitomycin C in patients with multiple prior occurrences of superficial bladder cancer.
作者信息
Schwarzman M I, Johanson K E, Surya B, Brown J
机构信息
Department of Urology, New York Veterans Administration Medical Center, New York.
出版信息
Urology. 1988 Oct;32(4):335-8. doi: 10.1016/0090-4295(88)90237-3.
PMID:3140465
Abstract
A limited course of intravesical mitomycin C was tested in 12 patients who had at least three, and an average of six, occurrences of superficial bladder cancer, and were at high risk for subsequent recurrences. After intravesical chemotherapy, recurrence rates were significantly less than rates prior to chemotherapy.
摘要
对12例浅表性膀胱癌患者进行了有限疗程的膀胱内丝裂霉素C治疗试验，这些患者至少发生过三次浅表性膀胱癌，平均发生六次，且后续复发风险较高。膀胱内化疗后，复发率显著低于化疗前。
Zotero 插件